News from daiichi sankyo europe gmbh A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

19 Oct, 2018, 07:00 BST Daiichi Sankyo Europe launches mycancertherapy.eu at ESMO 2018

New video-based website on cancer answers most frequently asked patient questions and simplifies medical jargon in 16 (EU & minority) different...


12 Dec, 2017, 12:51 GMT Once-Daily, Oral LIXIANA®▼ (edoxaban) Met Primary Endpoint in Investigational Hokusai-VTE CANCER Study

For EU media only – not for US journalists Hokusai-VTE CANCER study is a phase 3b, prospective, randomised, open-label, blind end-point (PROBE) study ...


26 Aug, 2015, 00:01 BST UK's NICE Recommends Once-daily LIXIANA® (Edoxaban) for the Treatment and Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in Adults

The National Institute for Health and Care Excellence (NICE), the medicines cost-effectiveness body for England and Wales, has today recommended a...


24 Aug, 2015, 06:00 BST Real World ETNA Registries of New Once-Daily LIXIANA▼® (edoxaban) Start in Europe

FOR UK MEDIA ONLY. Daiichi Sankyo announces enrollment of first patient in ETNA-AF-Europe and the commencement of ETNA-VTE-Europe, two regional...


24 Aug, 2015, 06:00 BST Real World ETNA Registries of New Once-Daily LIXIANA® (edoxaban) Start in Europe

FOR EU MEDIA ONLY. NOT FOR UK MEDIA. Daiichi Sankyo announces enrollment of first patient in ETNA-AF-Europe and the commencement of ETNA-VTE-Europe,...


25 Jun, 2015, 08:00 BST Daiichi Sankyo's Once-Daily LIXIANA® (edoxaban) Approved in the EU for Stroke Prevention in Nonvalvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent DVT and PE

Press release not intended for US and UK media EU approval paves the way for LIXIANA® (edoxaban) to be made available across all European member...


02 Jun, 2015, 08:01 BST Expert report highlights urgent action needed to lessen the future impact of Atrial Fibrillation in Europe

Report[1] recommendations aim to improve management of AF as numbers expected to double from 8.8 to 17.9 million adults aged over 55 years between...


24 Apr, 2015, 12:53 BST Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Receives Positive CHMP Opinion for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent Venous Thromboembolism in Europe

The European Committee for Medicinal Products for Human Use recommended approval of once-daily Lixiana® The positive opinion is based on data from...


27 Nov, 2014, 07:00 GMT European Cardiologists Highlight Risk of Delayed Diagnosis for Patients with Non-Valvular Atrial Fibrillation

Survey findings show that 97% of European cardiologists believe that non-valvular atrial fibrillation (NVAF) patients experience a delay in...


02 Sep, 2014, 14:00 BST One Year Data from the PREFER in AF Registry Show Significant Changes in Atrial Fibrillation (AF) Management in Europe and Implementation of Clinical Guidelines

Registry provides new insights into AF treatment decisions, including patients' quality of life and treatment satisfaction[1],[2] (Photo:...


02 Apr, 2014, 12:00 BST Daiichi Sankyo extends the PREFER in AF patient registry to provide additional insights into the long-term management of patients with atrial fibrillation

For UK Media Only Atrial fibrillation (AF) is the most common heart rhythm disorder[1] resulting in a five-fold increased risk of stroke compared...


25 Jun, 2013, 09:25 BST 23rd European Meeting on Hypertension and Cardiovascular Protection

New data from the SEVITENSION study show the fixed-dose combination treatment Sevikar® (olmesartan/amlodipine) to be superior to perindopril in...


08 Feb, 2013, 15:23 GMT European patient registry in venous thromboembolism (VTE)- PREFER in VTE -enrols first patient

The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the clinical...


06 Feb, 2013, 16:29 GMT European patient registry in venous thromboembolism (VTE) - PREFER in VTE - enrols first patient

The registry plans to gather data from more than 4,000 patients with VTE across seven European countries, providing insights into the clinical...


16 Jan, 2012, 07:00 GMT Pan-European Stroke Prevention in Atrial Fibrillation Registry - PREFER in AF - Enrols First Patient

- For European Media Only -- Collection of real life data from 5,000 atrial fibrillation patients (AF) across seven countries will generate...